Goserelin extended release - Luye Pharma GroupAlternative Names: Goserelin acetate extended release - Luye Pharma Group; LY 01005
Latest Information Update: 04 Oct 2016
At a glance
- Originator Luye Pharma Group
- Class Antineoplastics; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Breast cancer; Prostate cancer